- Home
- ASND vs MASI Comparison
ASND vs MASI Comparison
Compare ASND & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- MASI
- Stock Information
- Founded
- ASND 2006
- MASI 1989
- Country
- ASND Denmark
- MASI United States
- Employees
- ASND N/A
- MASI N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- MASI Medical/Dental Instruments
- Sector
- ASND Health Care
- MASI Health Care
- Exchange
- ASND Nasdaq
- MASI Nasdaq
- Market Cap
- ASND 7.7B
- MASI 8.8B
- IPO Year
- ASND 2015
- MASI 2007
- Fundamental
- Price
- ASND $152.43
- MASI $169.96
- Analyst Decision
- ASND Strong Buy
- MASI Buy
- Analyst Count
- ASND 14
- MASI 6
- Target Price
- ASND $197.36
- MASI $191.40
- AVG Volume (30 Days)
- ASND 519.7K
- MASI 412.5K
- Earning Date
- ASND 02-12-2025
- MASI 02-25-2025
- Dividend Yield
- ASND N/A
- MASI N/A
- EPS Growth
- ASND N/A
- MASI N/A
- EPS
- ASND N/A
- MASI 1.45
- Revenue
- ASND $376,478,932.00
- MASI $2,042,600,000.00
- Revenue This Year
- ASND $47.51
- MASI $3.90
- Revenue Next Year
- ASND $88.30
- MASI $2.21
- P/E Ratio
- ASND N/A
- MASI $117.36
- Revenue Growth
- ASND 36.34
- MASI N/A
- 52 Week Low
- ASND $111.09
- MASI $101.61
- 52 Week High
- ASND $161.00
- MASI $184.51
- Technical
- Relative Strength Index (RSI)
- ASND 66.26
- MASI 42.23
- Support Level
- ASND $118.03
- MASI $169.00
- Resistance Level
- ASND $157.37
- MASI $184.51
- Average True Range (ATR)
- ASND 6.50
- MASI 4.87
- MACD
- ASND 3.62
- MASI -0.72
- Stochastic Oscillator
- ASND 87.44
- MASI 6.19
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
About MASI Masimo Corporation
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.